Clinical Trials List
Protocol NumberTTYTU0307
Not yet recruiting
2004-04-01 - 2006-12-01
Phase II
Terminated3
-
Trial Applicant
TTY Biopharm Company Limited
-
Sponsor
-
Trial scale
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Hung-Ming Wang Division of Hematology & Oncology
- Tsai-Sheng Yang Division of Hematology & Oncology
- Chi-Ting Liau Division of Hematology & Oncology
- Wen-Cheng Chang Division of Hematology & Oncology
- 王正旭 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Principal Investigator
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Principal Investigator
Co-Principal Investigator
- 陳志丞 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
51 participants
-
Global
51 participants
